OSTENIL® is indicated to relieve pain and improve mobility in degenerative and traumatic changes of synovial joints degenerative changes, such as osteoarthritis.
The aim of the injection is to increase the concentration of hyaluronic acid in the joint, which often decreases as a result of osteoarthritis. The structure of the hyaluronic acid contained in OSTENIL®, OSTENIL® PLUS and OSTENIL® MINI matches human hyaluronic acid.
OSTENIL®: pre-filled syringe to relieve pain induced by osteoarthritis. Effective, safe and well-tolerated.
Inject OSTENIL® into the affected joint once a week for a total of 3–5 injections. Several joints may be treated at the same time. Depending on the severity of the joint disease the beneficial effects of a treatment cycle of five intra-articular injections will last at least six months. Repeat treatment cycles may be administered as required. In case of joint effusion it is advisable to reduce the effusion by aspiration, rest, application of an ice pack and/or intra-articular corticosteroid injection. Treatment with OSTENIL® can be started two to three days later. The content and the outer surface of the OSTENIL® pre-filled syringe are sterile as long as the sterile pack is intact. Take the pre-filled syringe out of the sterile pack, unscrew the Luer lock cap from the syringe, attach a suitable needle (for example 19 to 21 G) and secure it by turning slightly. Remove any air bubble, if present, before injection.